Host T cells affect donor T cell engraftment and graft-versus-host disease after reduced-intensity hematopoietic stem cell transplantation

被引:7
|
作者
Hardy, Nancy M.
Hakim, Frances
Steinberg, Seth M.
Krumlauf, Michael
Cvitkovic, Romana
Babb, Rebecca
Odom, Feanne
Fowler, Daniel H.
Gress, Ronald E.
Bishop, Michael R.
机构
[1] NIH, NCI, Ctr Canc Res, Expt Transplantat & Immunol Branch, Bethesda, MD 20892 USA
[2] Brigham Young Univ, Provo, UT 84602 USA
关键词
reduced-intensity stem cell transplantation; graft-versus-host disease; T cells; BONE-MARROW-TRANSPLANTATION; HEMATOLOGIC MALIGNANCIES; LYMPHOCYTE DEPLETION; LEUKOCYTE INFUSIONS; SIBLING DONORS; ADD-BACK; CHIMERISM; LEUKEMIA; RECONSTITUTION; CHEMOTHERAPY;
D O I
10.1016/j.bbmt.2007.05.008
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Mixed chimerism in the T cell compartment (MC,) after reduced-intensity stem cell transplantation (RIST) may influence immune repopulation with alloreactive donor T cells. We examined effects of host T cell numbers on donor T cell engraftment and recovery and on acute graft-versus-host disease (aGVHD) in a relatively homogeneous patient population with respect to residual host T cells through quantified immune depletion prior to RIST and to donor T cells by setting the allograft T cell dose of 1 x 10(5) CD3(+) cells/kg. In this setting, 2 patterns of early donor T cell engraftment could be distinguished by day +42: (1) early and complete donor chimerism in the T cell compartment (FDCT) and (2) persistent MCT. FDCT was associated with lower residual host CD8(+) T cell counts prior to transplant and aGVHD. With persistent MCTI subsequent development of aGVHD could be predicted by the direction of change in T cell donor chimerism after donor lymphocyte infusion, and no aGVHD occurred until FDCT was established. MCT did not affect recovery of donor T cell counts. These observations suggest that the relative number and alloreactivity of donor and host T cells are more important than the absolute allograft T cell dose in determining donor engraftment and aGVHD after RIST. (c) 2007 American Society for Blood and Marrow Transplantation
引用
收藏
页码:1022 / 1030
页数:9
相关论文
共 50 条
  • [1] Engraftment syndrome after reduced-intensity allogeneic hematopoietic stem cell transplantation: Impact of graft-versus-host disease prophylaxis and T cell dose.
    Dean, RM
    Donley, KM
    Gea-Banacloche, J
    Steinberg, SM
    Odom, J
    Krumlauf, M
    Castro, K
    Chinn, T
    Fowler, DH
    Gress, RE
    Bishop, MR
    BLOOD, 2004, 104 (11) : 345B - 346B
  • [2] Chronic graft-versus-host disease after reduced-intensity stem cell transplantation versus conventional hematopoietic stem cell transplantation
    Busca, A
    Rendine, S
    Locatelli, F
    Sizzano, F
    Dall'Omo, AM
    Rossi, G
    Falda, M
    HEMATOLOGY, 2005, 10 (01) : 1 - 10
  • [3] Development of graft-versus-host disease depends upon establishment of complete donor T cell chimerism after T cell depleted, reduced intensity hematopoietic stem cell transplantation
    Hardy, NM
    Steinberg, SM
    Krumlauf, M
    Cvitkovic, R
    Castro, K
    Hakim, F
    Carter, C
    Read, EJ
    Leitman, S
    Gress, R
    Bishop, MR
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (02) : 39 - 39
  • [4] Peripheral host T cells survive hematopoietic stem cell transplantation and promote graft-versus-host disease
    Divito, Sherrie J.
    Aasebo, Anders T.
    Matos, Tiago R.
    Hsieh, Pei-Chen
    Collin, Matthew
    Elco, Christopher P.
    O'Malley, John T.
    Baekkevold, Espen S.
    Reims, Henrik
    Gedde-Dahl, Tobias
    Hagerstrom, Michael
    Hilaire, Jude
    Lian, John W.
    Milford, Edgar L.
    Pinkus, Geraldine S.
    Ho, Vincent T.
    Soiffer, Robert J.
    Kim, Haesook T.
    Mihm, Martin C.
    Ritz, Jerome
    Guleria, Indira
    Cutler, Corey S.
    Clark, Rachael A.
    Jahnsen, Frode L.
    Kupper, Thomas S.
    JOURNAL OF CLINICAL INVESTIGATION, 2020, 130 (09): : 4624 - 4636
  • [5] Chronic graft-versus-host disease (cGVHD) after reduced-intensity stem cell transplantation (RIST) versus conventional stem cell transplantation (CST).
    Busca, A
    Falda, M
    Dall'Omo, AM
    Sizzano, F
    Aliberti, S
    Audisio, E
    Locatelli, F
    BLOOD, 2003, 102 (11) : 721A - 721A
  • [6] Graft-versus-Host Disease in a Dog After Reduced-intensity Hematopoietic Stem Cell Transplantation from a DLA-identical Littermate
    Schaefer, Stephanie
    Werner, Juliane
    Lange, Sandra
    Machka, Christoph
    Knuebel, Gudrun
    Sekora, Anett
    Roolf, Catrin
    Winkler, Tido
    Escobar, Hugo Murua
    Nolte, Ingo
    Junghanss, Christian
    IN VIVO, 2016, 30 (04): : 427 - 432
  • [7] Helper T-Cell Differentiation in Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation
    Jianing Fu
    Jessica Heinrichs
    Xue-Zhong Yu
    Archivum Immunologiae et Therapiae Experimentalis, 2014, 62 : 277 - 301
  • [8] Helper T-Cell Differentiation in Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation
    Fu, Jianing
    Heinrichs, Jessica
    Yu, Xue-Zhong
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2014, 62 (04) : 277 - 301
  • [9] MARAVIROC CONCENTRATIONS ARE HIGHLY PREDICTIVE OF ACUTE GRAFT-VERSUS-HOST DISEASE IN REDUCED-INTENSITY ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
    Ganetsky, A.
    Crisalli, L. M.
    Huffman, A. P.
    Acosta, E. P.
    Mangan, J. K.
    Luger, S. M.
    Loren, A. W.
    Hexner, E. O.
    Frey, N. V.
    Stadtmauer, E. A.
    Hoxie, J. A.
    Vonderheide, R. H.
    Porter, D. L.
    Reshef, R.
    HAEMATOLOGICA, 2016, 101 : 109 - 110
  • [10] Inflammatory cytokines and acute graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation
    Mohty, M
    Blaise, D
    Faucher, C
    Vey, N
    Bouabdallah, R
    Stoppa, AM
    Viret, F
    Gravis, G
    Olive, D
    Gaugler, B
    BLOOD, 2005, 106 (13) : 4407 - 4411